-+ 0.00%
-+ 0.00%
-+ 0.00%

Barinthus Biotherapeutics Q4 EPS $(0.27) Beats $(0.40) Estimate

Benzinga·03/13/2026 12:07:10
Listen to the news
Barinthus Biotherapeutics (NASDAQ:BRNS) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.40) by 32.5 percent. This is a 47.06 percent increase over losses of $(0.51) per share from the same period last year.